239 related articles for article (PubMed ID: 16840716)
21. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
[TBL] [Abstract][Full Text] [Related]
22. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
Chen J; Chen JK; Neilson EG; Harris RC
J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
[TBL] [Abstract][Full Text] [Related]
23. Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation.
Saito S; Frank GD; Motley ED; Dempsey PJ; Utsunomiya H; Inagami T; Eguchi S
Biochem Biophys Res Commun; 2002 Jun; 294(5):1023-9. PubMed ID: 12074579
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol blocks Akt activation in angiotensin II- or EGF-stimulated vascular smooth muscle cells in a redox-independent manner.
Schreiner CE; Kumerz M; Gesslbauer J; Schachner D; Joa H; Erker T; Atanasov AG; Heiss EH; Dirsch VM
Cardiovasc Res; 2011 Apr; 90(1):140-7. PubMed ID: 21071431
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo.
Lv P; Miao SB; Shu YN; Dong LH; Liu G; Xie XL; Gao M; Wang YC; Yin YJ; Wang XJ; Han M
Circ Res; 2012 Aug; 111(6):697-707. PubMed ID: 22798525
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor.
Seta K; Sadoshima J
J Biol Chem; 2003 Mar; 278(11):9019-26. PubMed ID: 12522132
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid.
Freeman EJ; Sheakley ML; Clements RJ
Arch Biochem Biophys; 2010 Jun; 498(1):50-6. PubMed ID: 20388488
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells.
Woolfolk EA; Eguchi S; Ohtsu H; Nakashima H; Ueno H; Gerthoffer WT; Motley ED
Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1286-94. PubMed ID: 16033904
[TBL] [Abstract][Full Text] [Related]
30. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
Bouallegue A; Vardatsikos G; Srivastava AK
Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF
Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601
[TBL] [Abstract][Full Text] [Related]
32. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
33. A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation.
Yahata Y; Shirakata Y; Tokumaru S; Yang L; Dai X; Tohyama M; Tsuda T; Sayama K; Iwai M; Horiuchi M; Hashimoto K
J Biol Chem; 2006 May; 281(19):13209-13216. PubMed ID: 16543233
[TBL] [Abstract][Full Text] [Related]
34. Naked Polyamidoamine Polymers Intrinsically Inhibit Angiotensin II-Mediated EGFR and ErbB2 Transactivation in a Dendrimer Generation- and Surface Chemistry-Dependent Manner.
Akhtar S; El-Hashim AZ; Chandrasekhar B; Attur S; Benter IF
Mol Pharm; 2016 May; 13(5):1575-86. PubMed ID: 26985693
[TBL] [Abstract][Full Text] [Related]
35. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
36. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
Chan SL; Umesalma S; Baumbach GL
Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
[TBL] [Abstract][Full Text] [Related]
38. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling.
Zuo L; Ushio-Fukai M; Hilenski LL; Alexander RW
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1223-8. PubMed ID: 15142861
[TBL] [Abstract][Full Text] [Related]
39. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
[TBL] [Abstract][Full Text] [Related]
40. TRPC3 channel confers cerebrovascular remodelling during hypertension via transactivation of EGF receptor signalling.
Wang M; Tang YB; Ma MM; Chen JH; Hu CP; Zhao SP; Peng DQ; Zhou JG; Guan YY; Zhang Z
Cardiovasc Res; 2016 Jan; 109(1):34-43. PubMed ID: 26598506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
